SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees…
TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the…
DOYLESTOWN, Pa., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage…
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development…
Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF), a clinical-stage biotechnology company…
Trial to study Major Depressive Disorder using Optimi's GMP natural psilocybin capsules in conjunction with therapyVancouver, British Columbia--(Newsfile Corp. -…
BOSTON, Aug. 27, 2024 /PRNewswire/ -- Glytec, a trailblazer in diabetes and insulin management software, announced today the expansion of…
AI-powered Document Translator empowers users to streamline their processes to translate and globally distribute critical documents necessary for training and…
New financial leader joins leadership team to support continued growth ALEXANDRIA, Va., Aug. 27, 2024 /PRNewswire/ -- Bluesight, the leading…
WARNER ROBINS, Ga., Aug. 27, 2024 /PRNewswire/ -- Aquila Solutions, a prominent provider of regulatory solutions for small to medium-sized pharmaceutical…